Carl Zeiss Meditec AG (ETR:AFX – Get Free Report)’s stock price was up 1.5% during mid-day trading on Wednesday. The company traded as high as €30.12 and last traded at €29.52. Approximately 212,726 shares traded hands during trading, an increase of 125% from the average daily volume of 94,405 shares. The stock had previously closed at €29.08.
Carl Zeiss Meditec Price Performance
The company has a market cap of $2.94 billion, a price-to-earnings ratio of 16.86, a P/E/G ratio of 2.83 and a beta of 1.35. The firm has a 50-day moving average price of €30.54 and a 200 day moving average price of €27.66.
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data.
Further Reading
- Five stocks we like better than Carl Zeiss Meditec
- Costco Ends Its Fiscal Year on a High Note, Eyes Big Expansion
- Cracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic Problem
- Oracle’s Force Majeure Notice Exposes a Bigger Problem for the AI Build-Out
- Oil May Be Stronger Than It Looks—And Diamondback Is on Sale
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
